Literature DB >> 25232417

Mutant of leucine-rich repeat kinase 2 is not associated with non-motor symptoms in Chinese Parkinson's disease patients.

Maolin Hao1, Ning Pan1, Qinghua Zhang1, Xiaohong Wang1.   

Abstract

Non-motor symptoms (NMS) are common in patients with Parkinson's disease (PD). However, little is known about NMS in patients with mutant of leucine-rich repeat kinase 2 (LRRK2). This study aimed to elucidate the relationship between NMS in Chinese PD patients and to ascertain if there were differences in NMS between PD patients and mutant of LRRK2. 200 sporadic PD (sPD) patients were recruited from a Provincial Hospital Affiliated to Shandong University. The Non-motor Symptom Questionnaire (NMSQ) was used to screen for the presence of NMS. A mean of 9.73 NMS (SD=4.53) was reported per patient. Forgetfulness, constipation and daytime sleepiness were found to be the most frequent NMS. No differences were found in 9 domains analysis between PD with and without LRRK2 variants. Non-motor symptoms in PD are too important to remain undetected. There are no Clinical characteristics of NMS tend to be similar between LRRK2 variants carriers and non-carriers in Chinese sPD patients.

Entities:  

Keywords:  LRRK2 variants; NMS Quest; Parkinson’s disease; nocturia; on-motor symptoms

Year:  2014        PMID: 25232417      PMCID: PMC4161577     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

Review 1.  Epidemiology of Parkinson's disease and akinetic syndromes.

Authors:  C M Tanner; D A Aston
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

2.  The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire.

Authors:  K Ray Chaudhuri; Cristina Prieto-Jurcynska; Yogini Naidu; Tanya Mitra; Belen Frades-Payo; Susanne Tluk; Anne Ruessmann; Per Odin; Graeme Macphee; Fabrizio Stocchi; William Ondo; Kapil Sethi; Anthony H V Schapira; Juan Carlos Martinez Castrillo; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

3.  The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease.

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Monica M Kurtis; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2011-01-24       Impact factor: 10.338

4.  G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.

Authors:  Carles Gaig; María José Martí; Mario Ezquerra; Maria Jesús Rey; Adriana Cardozo; Eduardo Tolosa
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-08       Impact factor: 10.154

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 6.  A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis.

Authors:  Jean-Nicolas Cornu; Paul Abrams; Christopher R Chapple; Roger R Dmochowski; Gary E Lemack; Martin C Michel; Andrea Tubaro; Stephan Madersbacher
Journal:  Eur Urol       Date:  2012-07-20       Impact factor: 20.096

7.  Pain perception in patients with Parkinson's disease.

Authors:  Tomasz Tykocki; Anna Kornakiewicz; Tomasz Mandat; Paweł Nauman
Journal:  J Clin Neurosci       Date:  2013-02-26       Impact factor: 1.961

8.  The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population.

Authors:  Chin-Song Lu; Yah-Huei Wu-Chou; Marina van Doeselaar; Erik J Simons; Hsiu-Chen Chang; Guido J Breedveld; Alessio Di Fonzo; Rou-Shayn Chen; Yi-Hsin Weng; Szu-Chia Lai; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2008-08-21       Impact factor: 2.660

9.  Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.

Authors:  C Marras; B Schüle; B Schuele; R P Munhoz; E Rogaeva; J W Langston; M Kasten; C Meaney; C Klein; P M Wadia; S-Y Lim; R S-I Chuang; C Zadikof; T Steeves; K M Prakash; R M A de Bie; G Adeli; T Thomsen; K K Johansen; H A Teive; A Asante; W Reginold; A E Lang
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

10.  123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations.

Authors:  Francesc Valldeoriola; Carles Gaig; Africa Muxí; Ignacio Navales; Pilar Paredes; Francisco Lomeña; Andres De la Cerda; Mariateresa Buongiorno; Mario Ezquerra; Pilar Santacruz; Maria Jose Martí; Eduardo Tolosa
Journal:  J Neurol       Date:  2011-01-08       Impact factor: 4.849

View more
  1 in total

1.  Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.

Authors:  Qian Sun; Tian Wang; Tian-Fang Jiang; Pei Huang; Dun-Hui Li; Ying Wang; Qin Xiao; Jun Liu; Sheng-Di Chen
Journal:  Aging Dis       Date:  2016-05-27       Impact factor: 6.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.